|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
T2 Biosystems, Inc. (TTOO) |
|
|
$0.17 0.00 (0.00%) as of 4:30 Thu 10/12
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
16,340,000 |
Market
Cap: |
2.84(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.174 - $0.174 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile T2 Biosystems is an in vitro diagnostics company and engaged in the detection of sepsis-causing pathogens and antibiotic resistance genes. Co.'s products include: T2Dx® Instrument, which runs diagnostic tests from patient samples; T2Candida® Panel, which is a direct-from-blood test that identifies the lethal form of blood stream infections that cause sepsis candidemia; T2Bacteria® Panel, which is a direct-from-blood test that detects bacterial pathogens associated with sepsis; T2Resistance® Panel, which is a direct-from-blood test that detects resistance genes from both gram-positive and gram-negative pathogens; and T2SARS-CoV-2 Panel, which detect SARS-CoV-2, the coronavirus in patients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
55 |
48,345,853 |
Total Sell Value |
$0 |
$0 |
$133 |
$12,851,354 |
Total People Sold |
0 |
0 |
1 |
2 |
Total Sell Transactions |
0 |
0 |
1 |
9 |
End Date |
2025-02-06 |
2024-11-05 |
2024-05-07 |
2023-05-08 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Elsbree David B |
|
|
2024-09-13 |
4 |
S |
$2.42 |
$133 |
D/D |
(55) |
23 |
|
- |
|
Crg Partners Iii (cayman) Unlev Aiv I L.p. |
10% Owner |
|
2024-05-09 |
4 |
A |
$0.00 |
$0 |
I/I |
1,824,800 |
4,704,729 |
|
- |
|
Crg Partners Iii (cayman) Unlev Aiv I L.p. |
10% Owner |
|
2024-05-03 |
4 |
A |
$0.00 |
$0 |
I/I |
4,748,335 |
2,879,929 |
|
- |
|
Crg Partners Iii (cayman) Unlev Aiv I L.p. |
10% Owner |
|
2024-04-12 |
4 |
A |
$0.00 |
$0 |
I/I |
3,280,618 |
878,415 |
|
- |
|
Sperzel John J Iii |
See Remarks |
|
2024-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
67 |
400 |
|
- |
|
Gibbs Michael Terrence |
General Counsel |
|
2024-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
29 |
135 |
|
- |
|
Sprague John M |
Chief Financial Officer |
|
2024-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
29 |
141 |
|
- |
|
Gibbs Michael Terrence |
General Counsel |
|
2024-02-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
40 |
106 |
|
- |
|
Giffin Brett A. |
Chief Commercial Officer |
|
2024-02-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
13 |
77 |
|
- |
|
Sperzel John J Iii |
See Remarks |
|
2024-02-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
160 |
333 |
|
- |
|
Sprague John M |
Chief Financial Officer |
|
2024-02-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
40 |
112 |
|
- |
|
Crg Partners Iii (cayman) Unlev Aiv I L.p. |
10% Owner |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
824,220 |
488,273 |
|
- |
|
Giffin Brett A. |
Chief Commercial Officer |
|
2023-11-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
33 |
64 |
|
- |
|
Adams Laura Lee |
|
|
2023-10-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
7 |
37 |
|
- |
|
Crg Partners Iii (cayman) Lev Aiv I L.p. |
10% Owner |
|
2023-09-28 |
4 |
S |
$0.16 |
$1,125,959 |
I/I |
(7,148,945) |
0 |
|
2% |
|
Crg Partners Iii (cayman) Lev Aiv I L.p. |
10% Owner |
|
2023-09-27 |
4 |
S |
$0.19 |
$1,145,998 |
I/I |
(5,981,202) |
1,937,852 |
|
4% |
|
Crg Partners Iii (cayman) Lev Aiv I L.p. |
10% Owner |
|
2023-09-26 |
4 |
S |
$0.20 |
$1,082,359 |
I/I |
(5,392,920) |
3,559,165 |
|
14% |
|
Crg Partners Iii (cayman) Lev Aiv I L.p. |
10% Owner |
|
2023-09-25 |
4 |
S |
$0.25 |
$62,500 |
I/I |
(250,000) |
5,021,014 |
|
21% |
|
Crg Partners Iii (cayman) Lev Aiv I L.p. |
10% Owner |
|
2023-09-22 |
4 |
S |
$0.26 |
$1,314,534 |
I/I |
(5,079,344) |
5,088,781 |
|
32% |
|
Crg Partners Iii (cayman) Lev Aiv I L.p. |
10% Owner |
|
2023-09-21 |
4 |
S |
$0.30 |
$1,904,632 |
I/I |
(6,338,211) |
6,465,629 |
|
40% |
|
Crg Partners Iii (cayman) Lev Aiv I L.p. |
10% Owner |
|
2023-09-20 |
4 |
S |
$0.31 |
$2,408,302 |
I/I |
(7,753,710) |
8,183,716 |
|
42% |
|
Crg Partners Iii (cayman) Lev Aiv I L.p. |
10% Owner |
|
2023-09-19 |
4 |
S |
$0.37 |
$3,806,937 |
I/I |
(10,401,466) |
10,285,500 |
|
49% |
|
Elsbree David B |
|
|
2023-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,300 |
7,824 |
|
- |
|
Cumming John W |
|
|
2023-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,600 |
5,256 |
|
- |
|
Toft Robin |
|
|
2023-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,300 |
5,772 |
|
- |
|
321 Records found
|
|
Page 1 of 13 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|